GenMark Diagnostics Schedules First Quarter 2019 Financial Results Conference Call for April 30, 2019
April 15, 2019 07:45 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close...
GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Negative Panel
April 15, 2019 07:30 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it...
GenMark Diagnostics Reports Fourth Quarter and Full Year 2018 Results
February 21, 2019 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics Announces Expansion of Executive Leadership Team
February 21, 2019 16:03 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the...
GenMark Diagnostics to Participate in Upcoming Investor Conferences
February 20, 2019 16:55 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics Schedules Fourth Quarter and Full Year 2018 Financial Results Conference Call for February 21, 2019
February 07, 2019 16:43 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter earnings results after market close...
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2018
January 08, 2019 08:00 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel
December 26, 2018 08:00 ET
|
GenMark Diagnostics, Inc.
Two of Three ePlex Blood Culture Identification Panels Now Cleared for Marketing in the U.S. CARLSBAD, Calif., Dec. 26, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading...
GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Positive Panel
December 20, 2018 14:15 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it...
GenMark Diagnostics to Present at the J.P. Morgan Healthcare Conference
December 19, 2018 17:22 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...